Transcriptic Selected to Oversee Robotic Cloud Lab Platform for Lilly’s San Diego Biotechnology Center

Transcriptic announced today that it has entered into a multi-year collaboration agreement with Eli Lilly and Company whereby Lilly will license the Transcriptic Common Lab Environment (TCLE) to enable on-demand drug discovery operations at its San Diego Biotechnology Center.

Please to read the entire article.